| Q108857414 | A Systemic and Molecular Study of Subcellular Localization of SARS-CoV-2 Proteins |
| Q37647570 | A previously undescribed coronavirus associated with respiratory disease in humans |
| Q37184045 | A rapid point of care immunoswab assay for SARS-CoV detection |
| Q40099471 | Activation of human monocytes after infection by human coronavirus 229E. |
| Q42246665 | Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis |
| Q36837704 | Acute respiratory infections in persons with spinal cord injury |
| Q36171303 | An Outbreak of Human Coronavirus OC43 Infection and Serological Cross-reactivity with SARS Coronavirus |
| Q40561829 | An outbreak of coronavirus OC43 respiratory infection in Normandy, France |
| Q91717735 | COVID-19: Risk Groups, Mechanistic Insights, and Challenges |
| Q47965850 | Childhood severe acute respiratory syndrome, coronavirus infections and asthma |
| Q41580309 | Clinical characteristics and outcomes of severe rhinovirus-associated pneumonia identified by bronchoscopic bronchoalveolar lavage in adults: comparison with severe influenza virus-associated pneumonia |
| Q45293860 | Clinical features and outcomes of severe acute respiratory syndrome and predictive factors for acute respiratory distress syndrome |
| Q41591805 | Clinical relevance of rhinovirus infections among adult hospitalized patients |
| Q36881708 | Community-acquired viral pneumonia |
| Q40429766 | Comparative host gene transcription by microarray analysis early after infection of the Huh7 cell line by severe acute respiratory syndrome coronavirus and human coronavirus 229E. |
| Q28200848 | Coronavirus as a possible cause of severe acute respiratory syndrome |
| Q95617473 | Coronaviruses pathogenesis, comorbidities and multi-organ damage – A review |
| Q27676849 | Crystal structure-based exploration of the important role of Arg106 in the RNA-binding domain of human coronavirus OC43 nucleocapsid protein |
| Q33967472 | Crystallization and preliminary X-ray diffraction analysis of the N-terminal domain of human coronavirus OC43 nucleocapsid protein |
| Q89198781 | Current knowledge about the antivirals remdesivir (GS-5734) and GS-441524 as therapeutic options for coronaviruses |
| Q33541374 | Detection of human coronaviruses in children with acute gastroenteritis |
| Q57096902 | Development of a recombinant truncated nucleocapsid protein based immunoassay for detection of antibodies against human coronavirus OC43 |
| Q34143794 | Development of one-step, real-time, quantitative reverse transcriptase PCR assays for absolute quantitation of human coronaviruses OC43 and 229E |
| Q47736585 | Double-antigen sandwich ELISA for detection of antibodies to SARS-associated coronavirus in human serum |
| Q88600750 | EMERGING RESPIRATORY DISEASE - CORONAVIRUSES |
| Q37457784 | Elucidation of the stability and functional regions of the human coronavirus OC43 nucleocapsid protein |
| Q37866520 | Etiology of community-acquired pneumonia in hospitalized school-age children: evidence for high prevalence of viral infections. |
| Q64245065 | Fine Particulate Air Pollution and Hospital Utilization for Upper Respiratory Tract Infections in Beijing, China |
| Q48021682 | Frequent detection of human coronaviruses in clinical specimens from patients with respiratory tract infection by use of a novel real-time reverse-transcriptase polymerase chain reaction |
| Q47848155 | Frequent detection of respiratory viruses in adult recipients of stem cell transplants with the use of real-time polymerase chain reaction, compared with viral culture |
| Q40276002 | Genetic variability of human coronavirus OC43-, 229E-, and NL63-like strains and their association with lower respiratory tract infections of hospitalized infants and immunocompromised patients |
| Q48069412 | High prevalence of human rhinovirus C infection in Thai children with acute lower respiratory tract disease |
| Q36029342 | Human Bocavirus infection, Canada |
| Q34329485 | Human coronavirus 229E nonstructural protein 13: characterization of duplex-unwinding, nucleoside triphosphatase, and RNA 5'-triphosphatase activities |
| Q40516855 | Human coronavirus NL63 infection in Canada |
| Q51802441 | Human coronavirus and acute respiratory illness in older adults with chronic obstructive pulmonary disease. |
| Q33346409 | Human metapneumovirus infections in adults: another piece of the puzzle |
| Q34975376 | Human papillomavirus type 16 E7 peptide-directed CD8+ T cells from patients with cervical cancer are cross-reactive with the coronavirus NS2 protein |
| Q37173041 | Human rhinoviruses: the cold wars resume |
| Q35131864 | Immunology of viral respiratory tract infection in infancy |
| Q46715936 | Immunoreactivity characterisation of the three structural regions of the human coronavirus OC43 nucleocapsid protein by Western blot: implications for the diagnosis of coronavirus infection |
| Q35960543 | Infection of human alveolar macrophages by human coronavirus strain 229E. |
| Q89864744 | Inhibitory effects of glycopyrronium, formoterol, and budesonide on coronavirus HCoV-229E replication and cytokine production by primary cultures of human nasal and tracheal epithelial cells |
| Q31147725 | Integration of Global Analyses of Host Molecular Responses with Clinical Data To Evaluate Pathogenesis and Advance Therapies for Emerging and Re-emerging Viral Infections |
| Q34014960 | Mechanisms of severe acute respiratory syndrome pathogenesis and innate immunomodulation |
| Q34417623 | Monoclonal antibodies to SARS-associated coronavirus (SARS-CoV): identification of neutralizing and antibodies reactive to S, N, M and E viral proteins |
| Q47879112 | Monoclonal antibodies versus reverse transcription-PCR for detection of respiratory viruses in a patient population with respiratory tract infections admitted to hospital |
| Q37015811 | Multiplex MassTag-PCR for respiratory pathogens in pediatric nasopharyngeal washes negative by conventional diagnostic testing shows a high prevalence of viruses belonging to a newly recognized rhinovirus clade |
| Q39239315 | Oligomerization of the carboxyl terminal domain of the human coronavirus 229E nucleocapsid protein |
| Q55022514 | Outpatient Antibiotic Stewardship: A Growing Frontier-Combining Myxovirus Resistance Protein A With Other Biomarkers to Improve Antibiotic Use. |
| Q37029615 | Pathogen-directed therapy in acute exacerbations of chronic obstructive pulmonary disease |
| Q57010461 | Pre-Clinical and Clinical Efficiency of Complexes of Oligoribonucleotides with D-Mannitol against Respiratory Viruses |
| Q51637154 | Presence of specific viruses in the middle ear fluids and respiratory secretions of young children with acute otitis media. |
| Q34431990 | Prevalence of Antibodies to Four Human Coronaviruses Is Lower in Nasal Secretions than in Serum |
| Q35587464 | Pulmonary pathological features in coronavirus associated severe acute respiratory syndrome (SARS). |
| Q36487512 | Rhino/enteroviruses in hospitalized children: a comparison to influenza viruses. |
| Q30310805 | Rhinovirus Infections in Hematopoietic Stem Cell Transplant Recipients with Pneumonia |
| Q51717782 | Rhinovirus and coronavirus infection-associated hospitalizations among older adults. |
| Q30312290 | Rhinovirus and the lower respiratory tract |
| Q36735531 | Rhinovirus-associated hospitalizations in young children |
| Q36264451 | Rhinoviruses are a major cause of wheezing and hospitalization in children less than 2 years of age. |
| Q40516466 | SARS and its impact on current and future Emergency Department operations |
| Q36144565 | SARS-CoV regulates immune function-related gene expression in human monocytic cells. |
| Q40312974 | SARS-associated coronavirus replication in cell lines |
| Q30333365 | Severe acute respiratory syndrome--a new coronavirus from the Chinese dragon's lair. |
| Q36297546 | Severe acute respiratory syndrome: what have we learned |
| Q48009341 | Structural characterization of the SARS-coronavirus spike S fusion protein core. |
| Q37588593 | The human rhinovirus: human-pathological impact, mechanisms of antirhinoviral agents, and strategies for their discovery. |
| Q54604182 | The relationship of rhinovirus-associated asthma hospitalizations with inhaled corticosteroids and smoking. |
| Q47242360 | Tissue and cellular tropism of the coronavirus associated with severe acute respiratory syndrome: an in-situ hybridization study of fatal cases |
| Q37072079 | Understanding the mechanisms of viral induced asthma: new therapeutic directions |
| Q31119325 | Update on Human Rhinovirus and Coronavirus Infections |
| Q33259544 | Upregulation of mitochondrial gene expression in PBMC from convalescent SARS patients |
| Q34257792 | Viral diversity in asthma |
| Q36372029 | Viral pneumonia in older adults |
| Q47217367 | Viral replication in the nasopharynx is associated with diarrhea in patients with severe acute respiratory syndrome |
| Q36823154 | What is the role of virus vaccination in patients with asthma? |